Has Trump’s “god drug” proven effective? The antimalarial drug hydroxychloroquine can reduce the death rate of newly crowned patients, the Henry Ford Health System of the United States said in a recent study, according to U.S. media reports. That conclusion was endorsed by Mr. Trump, who also tweeted that it was “disgraceful” that Democrats had previously belittled hydroxyl for “political reasons.” CNN, however, cautions that the findings have in fact been questioned by several experts…
The antimalarial drug hydroxychloroquine helps reduce mortality in patients with new crowns and does not have side effects affecting the heart, a study published Tuesday in the Journal of International Infectious Diseases, CBS News reported.
“Our analysis shows that the use of hydroxychloroquine can save lives,” said Steven Karkanis, chief executive of Henry Ford Healthcare Systems. And the data here clearly show that it is beneficial to treat inpatients with this drug. “
Trump, who has been controversial in the study’s findings, also tweeted his approval on Saturday night local time. He wrote: “The respected Henry Ford Health System reports that hydroxychloroquine has significantly reduced mortality in some patients based on a large sample. Democrats, on the other hand, have had political reasons (that’s me!). and belittle it! It’s a shame. At the end of the tweet, he asked the U.S. Drug Enforcement Administration (FDA) to “take immediate action.”
CNN, however, offers a different view of the study. In an article titled “Research has found that hydroxychloroquine may improve survival rates, but other experts are skeptical,” CNN wrote that experts who were not involved in the study said that henry Ford’s team did not randomly select patients in the study, but chose patients to cooperate with the treatment based on “certain criteria.”
In response, Eli Rosenberg, an associate professor of epidemiology at New York University, said the study excluded “very sick” patients and “could make the results inaccurate.” “
In addition, Dr. Todd Lee and colleagues at the Royal Victoria Hospital in Montreal, Canada, wrote in a commentary in the same journal: “Henry Ford’s health system is becoming more experienced in the treatment of new coronary pneumonia, so survival rates may improve regardless of the specific treatment they use.” Todd Lee also said the results could be “better” if the experiment used another drug, dexamethasone.
On June 17th the World Health Organisation welcomed the positive results of the British research team’s treatment of patients with the new crown, but warned that the drug should not be used in patients with new crowns or for prevention.
Originally: U.S. research agency says hydroxyl quince can reduce new crown deaths, Trump: Democrats have been belittling it before because I’m shameful!